Trump makes announcement on weight loss drug prices
Digest more
10hon MSN
This next-gen weight-loss drug offers a new hope — and a bonus Ozempic and Wegovy don’t have
Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up to 20.1 percent of their body weight on eloralintide.
This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some medications FDA-approved for type 2 diabetes can
Pfizer has clinched a deal worth up to $10bn to buy weight-loss start-up Metsera, capping a dramatic takeover battle after Ozempic maker Novo Nordisk tried to gatecrash its earlier bid.
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.
This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives for weight loss include the injections Wegovy®, Mounjaro®, Zepbound®,
Novo Nordisk lowered its guidance in part due to disappointing demand for Ozempic. Key Takeaways. Novo Nordisk cut its outlook as it sees
Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from U.S. pharma giant Pfizer. On Monday, Pfizer said it had filed a second lawsuit against Novo and Metsera, arguing that Novo's bid for the smaller company was anticompetitive.
Feedback